Author pages are created from data sourced from our academic publisher partnerships and public sources.
Responses of cerebral arteries and arterioles to acute hypotension and hypertension.
- H. Kontos, E. P. Wei, R. Navari, J. Levasseur, W. Rosenblum, J. Patterson
- Biology, Medicine
- The American journal of physiology
- 1 April 1978
The responses of cerebral precapillary vessels to changes in arterial blood pressure were studied in anesthetized cats equipped with cranial windows for the direct observation of the pial… Expand
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
BACKGROUND We examined the efficacy of olanzapine for the prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy. METHODS In a randomized, double-blind, phase 3… Expand
Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial.
BACKGROUND The purpose of the study was to compare the effectiveness of olanzapine (OLN) and aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients… Expand
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
PurposeOlanzapine has been shown to be a safe and effective agent for the prevention of chemotherapy-induced nausea and vomiting (CINV). Olanzapine may also be an effective rescue medication for… Expand
Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma
The objective of this study was to compare the efficacy and toxicity of the liposome‐encapsulated doxorubicin, TLC D‐99 (Myocet, Elan Pharmaceuticals, Princeton, NJ), and conventional doxorubicin in… Expand
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
- R. Navari, R. R. Reinhardt, +9 authors B. Gertz
- The New England journal of medicine
- 21 January 1999
BACKGROUND The localization of substance P in brain-stem regions associated with vomiting, and the results of studies in ferrets, led us to postulate that a neurokinin-1-receptor antagonist would be… Expand
Antimicrobial use in patients with advanced cancer receiving hospice care.
- P. H. White, Heather L Kuhlenschmidt, B. G. Vancura, R. Navari
- Journal of pain and symptom management
- 1 May 2003
Patients with advanced cancer receiving hospice and palliative care are highly susceptible to infections. The decision whether to treat an active or suspected infection in end-of-life care may be… Expand
Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting
- R. Navari
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles and… Expand
Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy
Background Studies have shown that there is a high prevalence of depression in cancer patients. Women with breast cancer may have an even higher risk of depression particularly in a postmenopausal or… Expand
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two…
BACKGROUND Highly emetogenic chemotherapy induces emesis in almost all patients in the absence of prophylaxis. Guidelines recommend use of a neurokinin-1 (NK-1) receptor antagonist in conjunction… Expand